A new analysis represents the largest effort yet to systematically parse all the data from high-quality clinical trials on cannabis and mental health. The evidence is lacking.
medical research
Posted inNPR
This 4-year-old’s heart is failing. A federal grant that might help him was canceled
A Cornell University researcher has been developing an artificial heart for children for more than 20 years. Now, his research is on hold and his lab is shut down.
Posted inNPR
VA research brought CT scans and pacemakers into the world. Now it’s at risk of cuts
Researchers at the Department of Veterans Affairs warn that crucial medical research is in jeopardy unless the Trump administration reverses course on cuts.
Posted inNPR
NIH partially lifts freeze on funding process for medical research
Thousands of grant applications had been stalled when the Trump administration blocked the National Institutes of Health from posting notices to the Federal Register.
Posted inNPR
NIH funding freeze stalls applications on $1.5 billion in medical research funds
The National Institutes of Health had to stop considering new grant applications, delaying funding for research into diseases ranging from heart disease and cancer to Alzheimer’s and allergies.
Posted inNPR
Sen. Ted Cruz’s list of “woke” science includes self-driving cars, solar eclipses
Sen. Ted Cruz, R-Texas, says the National Science Foundation has given money to thousands of “Woke DEI” studies. Researchers say that’s misrepresenting science and disparaging important research.
Posted inNPR
What National Institutes of Health funding cuts could mean for U.S. universities
What do National Institutes of Health funding cuts mean for universities? We ask Holden Thorp, editor-in-chief of the journal Science and former University of North Carolina at Chapel Hill chancellor.
Posted inNPR
NIH announces new funding policy that rattles medical researchers
The National Institutes of Health has dramatically changed its grant-making terms by limiting how much it will disperse for costs such as equipment and administration.
Posted inNPR
Fragile X held him back. An experimental drug is helping him break free
For 22 years, Jason Mazzola’s life was defined by a genetic condition that can cause autism and intellectual disability. Then he started taking an experimental drug.
